Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 13, September

Editorial [Hot topic: Chemokine Receptors as Targets in Medicinal Chemistry and Drug Discovery (Guest Editors: J. Robert Merritt and Maria Webb)]

Volume:10   Issue: 13
Pp: 1249-1249
J. Robert Merritt and Maria Webb
DOI: 10.2174/156802610791561200
Published on: 01 March, 2012

CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View

Volume:10   Issue: 13
Pp: 1250-1267
Jinqi Liu and J. Robert Merritt
DOI: 10.2174/156802610791561192
Published on: 01 March, 2012

CCR1 Antagonists: What Have We Learned From Clinical Trials

Volume:10   Issue: 13
Pp: 1268-1277
Ronald P. Gladue, Matthew F. Brown and Samuel H. Zwillich
DOI: 10.2174/156802610791561237
Published on: 01 March, 2012

CCR2 Antagonists

Volume:10   Issue: 13
Pp: 1278-1298
Mary Struthers and Alexander Pasternak
DOI: 10.2174/156802610791561255
Published on: 01 March, 2012

Small Molecule Antagonists of the Chemokine Receptor CCR5

Volume:10   Issue: 13
Pp: 1299-1338
Remy C. Lemoine and Jutta Wanner
DOI: 10.2174/156802610791561219
Published on: 01 March, 2012

Discovery of 3,4-Diaminocyclobut-3-ene-1,2-dione-Based CXCR2 Receptor Antagonists for the Treatment of Inflammatory Disorders

Volume:10   Issue: 13
Pp: 1339-1350
Michael P. Dwyer and Purakattle Biju
DOI: 10.2174/156802610791561246
Published on: 01 March, 2012

Small Molecule Antagonists of Chemokine Receptors - is Promiscuity a Virtue?

Volume:10   Issue: 13
Pp: 1351-1358
James E. Pease and Richard Horuk
DOI: 10.2174/156802610791561228
Published on: 01 March, 2012